• Price (USD)255.47
  • Today's Change4.17 / 1.66%
  • Shares traded1.58m
  • 1 Year change-15.32%
  • Beta1.2988
Data delayed at least 15 minutes, as of Mar 31 2023 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and instruments and accessories. Its da Vinci products consist of five categories, such as da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a suite of systems, learning, and services offerings. Its Ion endoluminal system extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Its services include readiness support, maintenance support, perioperative consulting, customer hospital analytics, and market consulting optimization.

  • Revenue in USD (TTM)6.22bn
  • Net income in USD1.32bn
  • Incorporated1995
  • Employees12.12k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
DexCom, Inc.2.91bn341.20m44.21bn7.50k142.8520.7388.9315.190.80090.80096.845.520.56363.054.74387,973.306.616.488.797.8565.1966.5811.7311.041.831,012.750.48780.0018.8432.2857.3143.7940.77--
Edwards Lifesciences Corp5.38bn1.52bn49.44bn17.30k33.458.5529.769.192.442.448.629.550.6411.358.79311,121.4018.1216.3220.6519.0479.9676.3228.2824.432.17--0.09310.002.869.401.2511.648.57--
Becton Dickinson and Co18.74bn1.49bn69.48bn77.00k47.362.7318.603.715.185.3065.3489.720.35193.128.40243,350.702.962.213.422.5144.7845.788.416.550.59956.320.392586.56-1.369.312.058.456.00--
Boston Scientific Corporation12.68bn642.00m71.29bn45.00k111.214.0540.035.620.4460.4468.8112.260.3922.266.77281,822.202.162.752.473.2869.0069.035.527.
Intuitive Surgical, Inc.6.22bn1.32bn88.02bn12.12k68.817.9750.6814.153.653.6517.1931.550.46912.747.21513,382.8010.1412.8611.2814.2967.4468.3021.6127.143.77--
Medtronic PLC30.77bn4.06bn105.34bn95.00k26.032.0515.503.423.043.0423.0638.670.3312.075.43323,915.804.405.085.045.7266.7268.4613.2915.451.3923.050.352762.615.211.3043.974.581.767.94
Stryker Corp18.45bn2.36bn106.42bn51.00k45.496.4031.715.776.176.1748.2743.880.5161.865.60361,745.106.596.437.777.5963.1464.8712.7812.790.9964--0.439944.457.848.1918.254.94-0.336710.77
Data as of Mar 31 2023. Currency figures normalised to Intuitive Surgical Inc's reporting currency: US Dollar USD

Institutional shareholders

34.43%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202227.94m7.98%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 202220.88m5.96%
BlackRock Fund Advisorsas of 31 Dec 202216.61m4.74%
SSgA Funds Management, Inc.as of 31 Dec 202214.89m4.25%
Capital Research & Management Co. (World Investors)as of 31 Dec 20227.44m2.12%
AllianceBernstein LPas of 31 Dec 20227.37m2.10%
Fidelity Management & Research Co. LLCas of 31 Dec 20226.73m1.92%
Edgewood Management LLCas of 31 Dec 20226.64m1.90%
Geode Capital Management LLCas of 31 Dec 20226.38m1.82%
JPMorgan Investment Management, Inc.as of 31 Dec 20225.76m1.64%
More ▼
Data from 31 Dec 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.